Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 2925-2940
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2925
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2925
Table 1 Characteristics of colorectal cancer patients with and without disabilities, n (%)
| People without disabilities | People with disability | By disability grade | By disability type | |||||||
| Grades 1-3 | Grades 4-6 | Physical | Communication | Brain | Mental | Cardiopulmonary | Others | |||
| All subject, n | 81069 | 19664 | 6517 | 13147 | 10727 | 5267 | 2013 | 463 | 386 | 808 |
| Age, yr | ||||||||||
| Mean (SD) | 68.6 (10.4) | 68.4 (10.5) | 67.8 (10.8) | 68.8 (10.3) | 67.3 (10.2) | 71.6 (10.4) | 70.4 (9.3) | 58.1 (11.5) | 69.2 (8.2) | 64.5 (10.7) |
| 19-40 | 700 (0.9) | 163 (0.8) | 80 (1.2) | 83 (0.6) | 81 (0.8) | 19 (0.4) | 7 (0.3) | 36 (7.8) | 0 (0) | 20 (2.5) |
| 40-65 | 27937 (34.5) | 6992 (35.6) | 2452 (37.6) | 4540 (34.5) | 4274 (39.8) | 1375 (26.1) | 533 (26.5) | 303 (65.4) | 120 (31.1) | 387 (47.9) |
| 65-75 | 31156 (38.4) | 7411 (37.7) | 2396 (36.8) | 5015 (38.1) | 4078 (38.0) | 1903 (36.1) | 872 (43.3) | 101 (21.8) | 188 (48.7) | 269 (33.3) |
| 75- | 21276 (26.2) | 5098 (25.9) | 1589 (24.4) | 3509 (26.7) | 2294 (21.4) | 1970 (37.4) | 601 (29.9) | 23 (5.0) | 78 (20.2) | 132 (16.3) |
| Female sex | 27371 (33.8) | 6460 (32.9) | 1928 (29.6) | 4532 (34.5) | 3717 (34.7) | 1612 (30.6) | 604 (30.0) | 180 (38.9) | 57 (14.8) | 290 (35.9) |
| Charlson comorbidity Score | ||||||||||
| Mean (SD) | 2.1 (1.1) | 2.4 (1.2) | 2.6 (1.2) | 2.3 (1.2) | 2.3 (1.2) | 2.3 (1.2) | 2.8 (1.2) | 2.1 (1.1) | 2.5 (1.2) | 3.3 (1.0) |
| 0 | 31441 (38.8) | 5390 (27.4) | 1597 (24.5) | 3793 (28.9) | 3255 (30.3) | 1601 (30.4) | 228 (11.3) | 203 (43.8) | 33 (8.5) | 70 (8.7) |
| 1 | 20410 (25.2) | 4501 (22.9) | 1304 (20.0) | 3197 (24.3) | 2571 (24.0) | 1281 (24.3) | 395 (19.6) | 114 (24.6) | 87 (22.5) | 53 (6.6) |
| 2 | 12609 (15.6) | 3288 (16.7) | 1099 (16.9) | 2189 (16.7) | 1785 (16.6) | 900 (17.1) | 331 (16.4) | 64 (13.8) | 93 (24.1) | 115 (14.2) |
| 3 | 7370 (9.1) | 2378 (12.1) | 779 (12.0) | 1599 (12.2) | 1240 (11.6) | 596 (11.3) | 317 (15.7) | 36 (7.8) | 71 (18.4) | 118 (14.6) |
| ≥ 4 | 9239 (11.4) | 4107 (20.9) | 1738 (26.7) | 2369 (18.0) | 1876 (17.5) | 889 (16.9) | 742 (36.9) | 46 (9.9) | 102 (26.4) | 452 (55.9) |
| Comorbidity | ||||||||||
| Hypertension | 38225 (47.2) | 10902 (55.4) | 3798 (58.3) | 7104 (54.0) | 5550 (51.7) | 2832 (53.8) | 1580 (78.5) | 131 (28.3) | 241 (62.4) | 568 (70.3) |
| Diabetes mellitus | 19632 (24.2) | 6039 (30.7) | 2169 (33.3) | 3870 (29.4) | 3109 (29.0) | 1531 (29.1) | 776 (38.5) | 82 (17.7) | 148 (38.3) | 393 (48.6) |
| Coronary heart disease | 9014 (11.1) | 2737 (13.9) | 1046 (16.1) | 1691 (12.9) | 1343 (12.5) | 697 (13.2) | 300 (14.9) | 25 (5.4) | 143 (37.0) | 229 (28.3) |
| Stroke | 4240 (5.2) | 2377 (12.1) | 1130 (17.3) | 1247 (9.5) | 789 (7.4) | 466 (8.8) | 998 (49.6) | 24 (5.2) | 28 (7.3) | 72 (8.9) |
| COPD | 19331 (23.8) | 5691 (28.9) | 1879 (28.8) | 3812 (29.0) | 3002 (28.0) | 1585 (30.1) | 522 (25.9) | 89 (19.2) | 267 (69.2) | 226 (28.0) |
| Income | ||||||||||
| Medical aid | 3816 (4.7) | 2536 (12.9) | 1329 (20.4) | 1207 (9.2) | 1155 (10.8) | 636 (12.1) | 287 (14.3) | 254 (54.9) | 59 (15.3) | 145 (17.9) |
| 1st quartile (lowest) | 13784 (17.0) | 3430 (17.4) | 955 (14.7) | 2475 (18.8) | 2019 (18.8) | 929 (17.6) | 255 (12.7) | 51 (11.0) | 51 (13.2) | 125 (15.5) |
| 2nd quartile | 13123 (16.2) | 3067 (15.6) | 946 (14.5) | 2121 (16.1) | 1759 (16.4) | 807 (15.3) | 272 (13.5) | 46 (9.9) | 63 (16.3) | 120 (14.9) |
| 3rd quartile | 18562 (22.9) | 4177 (21.2) | 1288 (19.8) | 2889 (22.0) | 2352 (21.9) | 1081 (20.5) | 455 (22.6) | 55 (11.9) | 90 (23.3) | 144 (17.8) |
| 4th quartile (highest) | 31784 (39.2) | 6454 (32.8) | 1999 (30.7) | 4455 (33.9) | 3442 (32.1) | 1814 (34.4) | 744 (37.0) | 57 (12.3) | 123 (31.9) | 274 (33.9) |
| Place of residence | ||||||||||
| Metropolitan | 46929 (57.9) | 10620 (54.0) | 3585 (55.0) | 7035 (53.5) | 5646 (52.6) | 2825 (53.6) | 1198 (59.5) | 221 (47.7) | 210 (54.4) | 520 (64.4) |
| City | 22329 (27.5) | 6009 (30.6) | 1983 (30.4) | 4026 (30.6) | 3341 (31.1) | 1633 (31.0) | 549 (27.3) | 147 (31.7) | 120 (31.1) | 219 (27.1) |
| Rural | 11811 (14.6) | 3035 (15.4) | 949 (14.6) | 2086 (15.9) | 1740 (16.2) | 809 (15.4) | 266 (13.2) | 95 (20.5) | 56 (14.5) | 69 (8.5) |
| Type of cancer | ||||||||||
| Colon | 44269 (54.6) | 10985 (55.9) | 3711 (56.9) | 7274 (55.3) | 5876 (54.8) | 2949 (56.0) | 1182 (58.7) | 278 (60.0) | 224 (58) | 476 (58.9) |
| Rectosigmoid | 6123 (7.6) | 1591 (8.1) | 530 (8.1) | 1061 (8.1) | 860 (8.0) | 449 (8.5) | 164 (8.1) | 46 (9.9) | 24 (6.2) | 48 (5.9) |
| Rectum | 30677 (37.8) | 7088 (36.0) | 2276 (34.9) | 4812 (36.6) | 3991 (37.2) | 1869 (35.5) | 667 (33.1) | 139 (30.0) | 138 (35.8) | 284 (35.1) |
| Clinical disease status | ||||||||||
| Localized | 29934 (36.9) | 7322 (37.2) | 2283 (35.0) | 5039 (38.3) | 4201 (39.2) | 1829 (34.7) | 664 (33.0) | 123 (26.6) | 150 (38.9) | 355 (43.9) |
| Locoregional | 34636 (42.7) | 7985 (40.6) | 2617 (40.2) | 5368 (40.8) | 4319 (40.3) | 2243 (42.6) | 832 (41.3) | 193 (41.7) | 142 (36.8) | 256 (31.7) |
| Metastatic | 9387 (11.6) | 2484 (12.6) | 889 (13.6) | 1595 (12.1) | 1279 (11.9) | 681 (12.9) | 298 (14.8) | 88 (19.0) | 50 (13.0) | 88 (10.9) |
| Unknown | 7112 (8.8) | 1873 (9.5) | 728 (11.2) | 1145 (8.7) | 928 (8.7) | 514 (9.8) | 219 (10.9) | 59 (12.7) | 44 (11.4) | 109 (13.5) |
| Treatment within 6 months of diagnosis | ||||||||||
| Polypectomy, EMR, or ESD | 11527 (14.2) | 2849 (14.5) | 877 (13.5) | 1972 (15.0) | 1683 (15.7) | 677 (12.9) | 223 (11.1) | 43 (9.3) | 63 (16.3) | 160 (19.8) |
| Surgery only | 31118 (38.4) | 7611 (38.7) | 2492 (38.2) | 5119 (38.9) | 4052 (37.8) | 2132 (40.5) | 801 (39.8) | 162 (35.0) | 147 (38.1) | 317 (39.2) |
| Surgery + RT | 2959 (3.6) | 587 (3.0) | 170 (2.6) | 417 (3.2) | 347 (3.2) | 149 (2.8) | 50 (2.5) | 11 (2.4) | 15 (3.9) | 15 (1.9) |
| Surgery + Chemo | 19409 (23.9) | 4140 (21.1) | 1233 (18.9) | 2907 (22.1) | 2467 (23.0) | 1058 (20.1) | 329 (16.3) | 113 (24.4) | 68 (17.6) | 105 (13.0) |
| Surgery + CCRT | 5339 (6.6) | 1034 (5.3) | 310 (4.8) | 724 (5.5) | 617 (5.8) | 284 (5.4) | 79 (3.9) | 17 (3.7) | 20 (5.2) | 17 (2.1) |
| CCRT | 691 (0.9) | 171 (0.9) | 68 (1.0) | 103 (0.8) | 82 (0.8) | 50 (0.9) | 15 (0.7) | 4 (0.9) | 11 (2.8) | 9 (1.1) |
| Chemo only | 2023 (2.5) | 558 (2.8) | 201 (3.1) | 357 (2.7) | 300 (2.8) | 134 (2.5) | 65 (3.2) | 23 (5.0) | 12 (3.1) | 24 (3.0) |
| RT only | 557 (0.7) | 155 (0.8) | 58 (0.9) | 97 (0.7) | 82 (0.8) | 44 (0.8) | 11 (0.5) | 4 (0.9) | 5 (1.3) | 9 (1.1) |
| No treatment | 7446 (9.2) | 2559 (13.0) | 1108 (17.0) | 1451 (11.0) | 1097 (10.2) | 739 (14.0) | 440 (21.9) | 86 (18.6) | 45 (11.7) | 152 (18.8) |
| Screening subset, n | 18760 | 3866 | 856 | 3010 | 2447 | 1072 | 216 | 27 | 53 | 51 |
| Smoking | ||||||||||
| Current | 5935 (31.6) | 1161 (30.0) | 267 (31.2) | 894 (29.7) | 754 (30.8) | 319 (29.8) | 58 (26.9) | 9 (33.3) | 7 (13.2) | 14 (27.5) |
| Past | 5146 (27.4) | 1054 (27.3) | 223 (26.1) | 831 (27.6) | 664 (27.1) | 290 (27.1) | 64 (29.6) | 6 (22.2) | 21 (39.6) | 9 (17.6) |
| Non | 7679 (40.9) | 1651 (42.7) | 366 (42.8) | 1285 (42.7) | 1029 (42.1) | 463 (43.2) | 94 (43.5) | 12 (44.4) | 25 (47.2) | 28 (54.9) |
| Alcohol intake | ||||||||||
| Non-drinker | 2082 (11.1) | 596 (15.4) | 151 (17.6) | 445 (14.8) | 353 (14.4) | 149 (13.9) | 47 (21.8) | 11 (40.7) | 19 (35.8) | 17 (33.3) |
| Social amount | 16096 (85.8) | 3128 (80.9) | 681 (79.6) | 2447 (81.3) | 2007 (82.0) | 873 (81.4) | 168 (77.8) | 15 (55.6) | 33 (62.3) | 32 (62.7) |
| Heavy drinker | 582 (3.1) | 142 (3.7) | 24 (2.8) | 118 (3.9) | 87 (3.6) | 50 (4.7) | 1 (0.5) | 1 (3.7) | 1 (1.9) | 2 (3.9) |
| BMI, kg/m2 | ||||||||||
| < 18.5 | 484 (2.6) | 100 (2.6) | 39 (4.6) | 61 (2) | 52 (2.1) | 34 (3.2) | 6 (2.8) | 2 (7.4) | 6 (11.3) | 0 (0) |
| 18.5-23.0 | 6105 (32.5) | 1260 (32.6) | 314 (36.7) | 946 (31.4) | 760 (31.1) | 367 (34.2) | 77 (35.6) | 11 (40.7) | 24 (45.3) | 21 (41.2) |
| 23.0-25.0 | 5227 (27.9) | 1009 (26.1) | 201 (23.5) | 808 (26.8) | 650 (26.6) | 281 (26.2) | 49 (22.7) | 8 (29.6) | 10 (18.9) | 11 (21.6) |
| 25.0-30.0 | 6438 (34.3) | 1347 (34.8) | 270 (31.5) | 1077 (35.8) | 878 (35.9) | 358 (33.4) | 77 (35.6) | 6 (22.2) | 12 (22.6) | 16 (31.4) |
| ≥ 30.0 | 506 (2.7) | 150 (3.9) | 32 (3.7) | 118 (3.9) | 107 (4.4) | 32 (3.0) | 7 (3.2) | 0 (0) | 1 (1.9) | 3 (5.9) |
- Citation: Kim KB, Shin DW, Yeob KE, Kim SY, Han JH, Park SM, Park JH, Park JH. Disparities in the diagnosis and treatment of colorectal cancer among patients with disabilities. World J Gastrointest Oncol 2024; 16(7): 2925-2940
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/2925.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.2925